Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nils Nickel, MD
University of Texas
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner University Medical Center
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Cottage Hospital
Santa Barbara, California, United States
- Wellstar Mcg Health Medical Center
Augusta, Georgia, United States
- Lifebridge Health
Baltimore, Maryland, United States
- Tuft University Hospital
Boston, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Wake Forest University/atrium Health'S Carolinas Medical Center
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Fairview Hospital
Cleveland, Ohio, United States
- Temple University Hospital
Philadelphia, Pennsylvania, United States
- Texas Tech University Health Sciences Center at El Paso
El Paso, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 May 2023
- Primary completion
- 31 Aug 2026
- Completion
- 30 Nov 2026
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 64
- Registry id
- NCT05408546
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.